News Articles for Stewart Washer

Board Moves December 22, 2023

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes John Seton, Ricardo Garzon Rangel, Troy Hayden, Quinton Meyers, Chris Zielinski, Stewart Washer, Andrew Woskett, Patrick Burke, Jerry Monzu, and Craig McNab.

Board Moves November 13, 2023

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Alistair Vickery, Stewart Washer, Karen Smith, Tracey Horton, Peter Gundy, Clint Moxham, Carla Healy, Damon Fieldgate, Paul Farrell, and Andrew Brown.

Board Moves October 25, 2023

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Lindiwe Mthimunye, Val Coetzee, Jonathan Velloza, John Welborn, Craig Mitchell, Andrew Tyrrell, Fiona Wood, Qi Xiao Zhou, Stewart Washer, Peter Harold, and Peter Venn.

Board Moves May 29, 2023

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Gregory Bittar, Josh Hunt, Ben Smith, John Van Der Wielen, and Stewart Washer.

Bill Gates backs Perth startup

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Climate technology company Rumin8 has raised $US12 million in a funding round led by the Bill Gates-founded Breakthrough Energy Ventures and supported by Andrew and Nicola Forrest.

Advisers enjoy strong flow of listings

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A post-pandemic bounce back in initial public offerings could indicate confidence among WA investors.

Perth cannabis companies raise $16m from IPOs

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Emerald Clinics and Little Green Pharma have both completed their initial public offerings ahead of stock market listings this month, with Emerald getting ready for its ASX debut tomorrow.

Medicinal cannabis IPOs seek $18m

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth companies Emerald Clinics and Little Green Pharma are seeking to raise up to $18 million ahead of stock market listings as they pursue very different strategies in the medicinal cannabis market.

Board Moves December 2, 2019

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our board moves wrap includes Mark Syropoulo, Cathy Moises, Kate Stoney, Bradley Marwood, Peter Bewick, Henko Vos, Abby Siew, Grant Mooney, Les Davis, Doron Nevo, Michael Soucik, Dan Smith, Swee Chen Goh, Osagie Imasogie, Lisa Gray, Oludare Odumosu, Harry Karelis, Mara Gordon, and Stewart Washer.

Zelda to merge with US cannabis company

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based Zelda Therapeutics has struck an agreement to merge with Ilera Therapeutics that could potentially be worth more than $65 million, as it seeks to grow in the heavily regulated global medical cannabis market.

Winlo joins Emerald Clinics

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Medicinal cannabis research company Emerald Clinics has boosted its management team with the appointment of Michael Winlo as chief executive, ahead of an expected IPO later this year.

Board Moves July 15-19, 2019

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

This weekly board moves wrap includes Vince Ippolito, Stewart Washer, Matthew Madden, Jason Stirbinskis, Rob McDonald, Evan Cranston, Tolga Kumova, Dror Nagel, Leigh Junk, Maggie Niewidok, Justin Mouchacca, Laurie Marsland, Michael Hardy, Matthew Carr, Cameron Henry, Robert Sckalor, and David McArthur.

Board Moves February 21, 2019

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Our daily board moves wrap includes David Blackhall, Stewart Washer, Ian Hobson, Raj Surendran, Chiew Sheng Tay, and Mark Okeby.

Strong returns for AusCann investors

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

SPECIAL REPORT: AusCann has benefited from a wave of interest in medicinal cannabis for pain relief to be the BN30's top performer in shareholder returns for the year to June 30.

Study cool on cannabis pain benefit

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A University of New South Wales study has called for caution about the potential benefits of medicinal cannabis to relieve pain, but a Western Australian hopeful in the sector is still confident for the future of the industry.

Hopkins to head Zelda Therapeutics

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based medicinal cannabis specialist Zelda Therapeutics has appointed former Phylogica and PharmAust chief executive Richard Hopkins as its managing director.

Zelda in cannabis autism trial

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Clinical trials company Zelda Therapeutics aims to pave the way for the use of medicinal cannabis to treat a range of disorders.

More firms target medical cannabis space

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

A medical cannabis company focused on animal health has announced plans to list on the ASX, while two other companies - including a pearling business - have made movements in the pharmaceutical space.

Poynton sets up new digs in CBD

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The lure of increasingly affordable commercial rents in the CBD has drawn boutique investment advisory firm Jindalee Partners from Subiaco.

Medical cannabis company seeks listing

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Shares in TW Holdings slumped sharply today after it announced a backdoor listing of medical cannabis company AusCann Group Holdings, the second deal of this type involving members of the Washer family.

Gleneagle targets biotech

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Gleneagle Gold will make a second attempt at a reverse takeover with plans to buy a local unlisted medical cannabis company in a deal worth about $8 million.

Orthocell unveils IPO plans

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth-based biotech firm Orthocell has confirmed it intends to list on the ASX after outlining plans for an $8 million initial public offering.

Orthocell considers IPO push

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Biotech player Orthocell has appointed two financial advisory firms to seek out investors as part of the company's plans to go public.

Universities draw the state’s heavy hitters into their fold

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

WHEN Celebrate WA announced Western Australia's Citizen of Year awards for 2009 two weekends ago the presence of the University of Western Australia would not have escaped the attention of many.

Phylogica seeks new CEO after Washer resigns

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Subiaco-based drug development company Phylogica Ltd is searching for a new chief executive after current chief Dr Stewart Washer announced he would be leaving the company in April next year.

Strong float for Phylogica

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Local biotechnology company Phylogica has listed on the Australian Stock Exchange, closing at a premium of 37.5 per cent over the subscription price of 20 cents on its first day.